structured coaching ecosystems integrated with GLPs
Additionally, semaglutide increases signals in your brain's nausea center as it adjusts to new appetite regulation patterns
As a triple agonist , it simultaneously activates three distinct receptor systems [5]: GIP (Glucose-dependent Insulinotropic Polypeptide) receptors enhance insulin secretion and may have direct effects on adipose tissue GLP-1 (Glucagon-like Peptide-1) receptors promote satiety, slow gastric emptying, and improve glucose regulation Glucagon receptors increase energy expenditure and may enhance fat oxidation This multi-receptor targeting strategy distinguishes retatrutide from single-pathway peptides and creates a complex metabolic profile that researchers are still working to fully characterize
Kim, D., Hwang, J.F.H., and Fendrick, A.M., Balancing innovation and affordability in anti-obesity medications: the role of an alternative weight-maintenance program, Health Affairs Scholar , May 2, 2024